These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
123 related items for PubMed ID: 6426395
1. [Pharmacokinetics of FT-207 rectum suppository in squamous cell carcinoma of the uterine cervix. (I) Pharmacokinetics in single administration at a dose of 1 gram]. Okazaki H, Hasegawa T, Fujimori T, Katayama S, Sakaguchi K, Hayashi Y, Nakagiri Y, Ishii Y, Fukui H, Kohno I. Gan To Kagaku Ryoho; 1984 Apr; 11(4):840-7. PubMed ID: 6426395 [Abstract] [Full Text] [Related]
2. [Pharmacokinetics of FT-207 rectum suppository in squamous cell carcinoma of the uterine cervix. (II) Pharmacokinetics in continuous administration at a daily dose of 1 gram]. Okazaki H, Hasegawa T, Endoh S, Hayashi Y, Chin N, Rin K, Nakagiri Y, Ishii Y, Fukui H, Kohno I. Gan To Kagaku Ryoho; 1984 Apr; 11(4):848-52. PubMed ID: 6426396 [Abstract] [Full Text] [Related]
3. [FT-207 and 5-FU concentrations in brain tumor tissues, plasma and CSF after administration of FT-207 suppository]. Matsuura H, Nakazawa S. Gan To Kagaku Ryoho; 1984 Apr; 11(4):912-6. PubMed ID: 6426399 [Abstract] [Full Text] [Related]
4. [Thermotherapy for cancer of the urinary bladder in combination with tegafur suppository and picibanil--concentrations of tegafur in the serum and tissues in bladder carcinoma]. Murahashi I, Mukae K, Tabata Y, Sakuma H, Kanbe K, Arai T, Kaneko K, Honda M, Maeda S, Takasaki E. Gan To Kagaku Ryoho; 1985 May; 12(5):1152-5. PubMed ID: 3922314 [Abstract] [Full Text] [Related]
5. [Preoperative treatment of FT-207 suppository in cervical cancer-- serum and tumor tissue content of FT-207]. Nagai S, Sawada T. Gan To Kagaku Ryoho; 1984 Feb; 11(2):307-11. PubMed ID: 6421248 [Abstract] [Full Text] [Related]
6. [Level of 5-FU in uterine cervical cancer tissue after oral administration of UFT]. Suzuki M, Sekiguchi I, Ohwada M, Tamada T. Gan To Kagaku Ryoho; 1985 Nov; 12(11):2139-44. PubMed ID: 3933435 [Abstract] [Full Text] [Related]
7. [Clinical evaluation of Tegafur suppository in the treatment of uterine cancer--with special reference to the drug concentration in the blood, secretion from the pelvic dead space, and tissues of female genital organs]. Yamada E. Igaku Kenkyu; 1982 Nov; 52(5):269-87. PubMed ID: 6821182 [No Abstract] [Full Text] [Related]
8. [Clinical study of serum and tissue concentrations of FT-207 and 5-FU in patients with cancer of the large intestine following preoperative application of FT-207 suppositories]. Okuda M, Teramoto T, Yoshida H, Sato K, Ushijima Y, Uematsu Y. Gan To Kagaku Ryoho; 1982 Sep; 9(9):1580-8. PubMed ID: 6820920 [Abstract] [Full Text] [Related]
9. [Pre- and intra-operative chemotherapy using FT-207 suppositories--with special reference to lung cancer]. Fukuda K, Komatubara S, Sato G, Teramoto S. Gan To Kagaku Ryoho; 1982 Dec; 9(12):2212-5. PubMed ID: 6307181 [Abstract] [Full Text] [Related]
12. [Serum concentration of 5-FU and tegafur (FT-207) after administration of tegafur (FT-207) suppository with the colostomy]. Kimoto M, Nagano H, Gunge N, Murei T, Iwamoto S, Seo Y, Yamamoto Y, Sano K. Gan To Kagaku Ryoho; 1987 Oct; 14(10):2853-8. PubMed ID: 3116942 [Abstract] [Full Text] [Related]
13. [The concentration of 5-fluorouracil in blood and tissues of the patients with carcinoma of the cervix after administration of UFT and 5-fluorouracil]. Yamashita K, Mitani K, Morishita Y, Inoue K. Gan To Kagaku Ryoho; 1989 Apr; 16(4 Pt 1):767-73. PubMed ID: 2496666 [Abstract] [Full Text] [Related]
14. [Fundamental studies on the introduction of chemotherapy of uterine cervical carcinoma--tissue level of 5-FU after oral administration]. Hattori K, Hareyama H, Ishizaki Y, Ohkubo H, Kanemoto T. Gan To Kagaku Ryoho; 1984 Oct; 11(10):2193-9. PubMed ID: 6486834 [Abstract] [Full Text] [Related]
15. [Study on the concentration of FT-207 and 5-FU in serum, lymph nodes and tissues after administration of FT-207 suppositories]. Kumazawa H, Imai N, Shioya M, Kato K, Fukaya Y, Noguchi A. Gan To Kagaku Ryoho; 1984 Aug; 11(8):1655-62. PubMed ID: 6433799 [Abstract] [Full Text] [Related]
16. [Pharmacokinetics of vaginal suppository FT-207 in uterine cervical cancer and radiation therapy]. Noda T, Kamamoto Y, Saitoh S, Nakanishi A, Ando Y, Tsuji Y, Yoh S, Moriyama I, Ichijo M. Nihon Gan Chiryo Gakkai Shi; 1984 May 20; 19(4):796-802. PubMed ID: 6436412 [No Abstract] [Full Text] [Related]
17. [Comparative pharmacokinetic study between UFT and FT-207 suppo and phase II studies in gynecological malignancies]. Hatae M, Terahara M, Hokanishi H. Gan To Kagaku Ryoho; 1984 Nov 20; 11(11):2386-92. PubMed ID: 6437345 [Abstract] [Full Text] [Related]
18. [Evaluation of pre-operative chemotherapy using FT-207 suppositories combined with glutathione--with special reference to histopathological antitumor effect]. Kaga F, Kitajima M, Ikeda Y, Seki M, Yagita A, Sohma S, Fukuzumi N. Gan To Kagaku Ryoho; 1982 Mar 20; 9(3):489-95. PubMed ID: 6820899 [Abstract] [Full Text] [Related]
19. [Effect of intravenous administration of FT-207 for gastric cancer]. Otani Y, Yamanaka T, Kikuchi H, Namatame K, Yoshida K, Kataba Y, Maruyama Y, Watanabe H. Gan To Kagaku Ryoho; 1985 Apr 20; 12(4):857-60. PubMed ID: 3920970 [Abstract] [Full Text] [Related]
20. [Clinical study on concentration of FT-207 and 5-FU in serum, lymph nodes and tissues after rectal administration of FT-207 suppositories for malignant diseases of the liver, biliary tract and pancreas]. Takada T, Yasuda H, Uchiyama K, Hasegawa H. Gan To Kagaku Ryoho; 1985 May 20; 12(5):1088-93. PubMed ID: 3922311 [Abstract] [Full Text] [Related] Page: [Next] [New Search]